skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8129

Pharmacogenomics of chronic hepatitis C therapy with genome-wide association studies

Review

(1195) Views  (1557) Full article downloads

Authors: Chun-Hsiang Wang, Yuchi Hwang, Eugene Lin

Published Date July 2010 Volume 2010:2 Pages 73 - 82
DOI: http://dx.doi.org/10.2147/JEP.S8655

Chun-Hsiang Wang1, Yuchi Hwang2, Eugene Lin2

1Department of Hepatogastroenterology, Tainan Municipal Hospital, Tainan, Taiwan; 2Vita Genomics, Inc., Taipei, Taiwan

Abstract: Chronic hepatitis C (CHC) is a liver disease characterized by infection with the hepatitis C virus (HCV) persisting for more than six months. Patients with CHC often stop pursuing the pegylated interferon (peg-IFN) and ribavirin (RBV) treatment because of the high cost and associated adverse effects. Therefore, it is highly desirable, both clinically and economically, to establish the determinants of response to distinguish responders from nonresponders, and to predict the possible outcomes of the peg-IFN and RBV treatments. The aim of this study was to review recent data on the pharmacogenomics of the drug efficacy of IFN in CHC patients. Single nucleotide polymorphisms (SNPs) can be used to understand the relationship between genetic inheritance and IFN therapeutic response. In the recent advent of scientific research, the genome-wide association study (GWAS), which is an alternative to the candidate-gene approach, is widely utilized to examine hundreds of thousands of SNPs by high-throughput genotyping technologies. In addition to the candidate-gene approach, the GWAS approach has recently been employed to study the determinants of HCV’s response to therapy. Several recent findings have demonstrated that some SNPs in the interleukin 28B gene are closely associated with IFN responsiveness. These results promise to lead to mechanistic findings related to IFN responsiveness in this disease, and will probably have major contributions for individualized medicine and therapeutic decision making.

Keywords: chronic hepatitis C, genome-wide association study, interferon, pharmacogenomics, ribavirin, single nucleotide polymorphisms






 

Other articles by Dr Eugene Lin

A common variant in the adiponectin gene on weight loss and body composition under sibutramine therapy in obesity
Association study of a brain-derived neurotrophic factor polymorphism and short-term antidepressant response in major depressive disorders
Identification of significant genes in genomics using Bayesian variable selection methods
Modeling short-term antidepressant responsiveness with artificial neural networks
Pharmacogenomics of drug efficacy in the interferon treatment of chronic hepatitis C using classification algorithms
Pilot study of an association between a common variant in the non-muscle myosin heavy chain 9 (MYH9) gene and type 2 diabetic nephropathy in a Taiwanese population
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University